Medicare reviews anemia drug use; Cleveland Clinic focuses on telemedicine;

> Medicare is pulling together a panel to discuss the best uses for anemia drugs Procrit, Aranesp and Epogen in chronic kidney disease. This isn't a big thrill for drugmakers Amgen and Johnson & Johnson, of course, who fear more restrictions. FiercePharma

> The Cleveland Clinic is planning a new focus on telemedicine initiatives, including eICUs and home healthcare support. FierceHealthIT

> A Boston hospital expects to save $7 million per year with an automated referral system. FierceHealthFinance

> Researchers have found a link between blood pressure and multiple sclerosis that could open an avenue to an inexpensive approach for treating the disabling condition. FierceBiotechResearch

And Finally... I bet this is the most interesting thing, by a huge margin, that he's ever found in the rough. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.